TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results